HighTower Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $2.7M | Buy |
18,040
+99
| +0.6% | +$15.1K | 0.26% | 64 |
|
|
2022
Q4 | $2.91M | Sell |
17,941
-2,557
| -12% | -$392K | 0.28% | 57 |
|
|
2022
Q3 | $2.75M | Buy |
20,498
+101
| +0.5% | +$14.5K | 0.3% | 59 |
|
|
2022
Q2 | $3.05K | Sell |
20,397
-4,406
| -18% | -$673K | 0.32% | 57 |
|
|
2022
Q1 | $4.02M | Buy |
24,803
+30
| +0.1% | +$4.36K | 0.38% | 45 |
|
|
2021
Q4 | $3.35M | Buy |
24,773
+658
| +3% | +$77.7K | 0.33% | 54 |
|
|
2021
Q3 | $2.6M | Sell |
24,115
-245
| -1% | -$28K | 0.32% | 59 |
|
|
2021
Q2 | $2.74M | Sell |
24,360
-1,483
| -6% | -$167K | 0.34% | 57 |
|
|
2021
Q1 | $2.8M | Sell |
25,843
-64
| -0.2% | -$6.85K | 0.37% | 53 |
|
|
2020
Q4 | $2.78M | Sell |
25,907
-5,088
| -16% | -$489K | 0.4% | 51 |
|
|
2020
Q3 | $2.71M | Sell |
30,995
-1,692
| -5% | -$159K | 0.43% | 48 |
|
|
2020
Q2 | $3.21M | Buy |
32,687
+168
| +0.5% | +$14.8K | 0.49% | 43 |
|
|
2020
Q1 | $2.48M | Sell |
32,519
-144
| -0.4% | -$12.3K | 0.43% | 46 |
|
|
2019
Q4 | $2.89M | Hold |
32,663
| – | – | 0.36% | 48 |
|
|
2019
Q3 | $2.47M | Sell |
32,663
-2,533
| -7% | -$174K | 0.31% | 52 |
|
|
2019
Q2 | $2.56M | Sell |
35,196
-194
| -0.5% | -$15.2K | 0.32% | 49 |
|
|
2019
Q1 | $2.85M | Sell |
35,390
-6,960
| -16% | -$569K | 0.37% | 42 |
|
|
2018
Q4 | $3.9M | Buy |
42,350
+6,854
| +19% | +$603K | 0.56% | 33 |
|
|
2018
Q3 | $3.36M | Hold |
35,496
| – | – | 0.37% | 40 |
|
|
2018
Q2 | $3.29M | Sell |
35,496
-60
| -0.2% | -$5.86K | 0.38% | 38 |
|
|
2018
Q1 | $3.37M | Sell |
35,556
-322
| -0.9% | -$35.4K | 0.41% | 36 |
|
|
2017
Q4 | $3.47M | Buy |
35,878
+322
| +0.9% | +$30.3K | 0.39% | 37 |
|
|
2017
Q3 | $3.16M | Sell |
35,556
-4,865
| -12% | -$370K | 0.38% | 37 |
|
|
2017
Q2 | $2.93M | Sell |
40,421
-460
| -1% | -$30.9K | 0.34% | 39 |
|
|
2017
Q1 | $2.66M | Sell |
40,881
-4,428
| -10% | -$278K | 0.3% | 43 |
|
|
2016
Q4 | $2.84M | Sell |
45,309
-4,212
| -9% | -$257K | 0.32% | 41 |
|
|
2016
Q3 | $3.12M | Sell |
49,521
-356
| -0.7% | -$23K | 0.35% | 39 |
|
|
2016
Q2 | $3.09M | Buy |
49,877
+675
| +1% | +$41.1K | 0.33% | 42 |
|
|
2016
Q1 | $2.81M | Sell |
49,202
-214
| -0.4% | -$11.9K | 0.35% | 35 |
|
|
2015
Q4 | $2.93M | Sell |
49,416
-8,847
| -15% | -$510K | 0.39% | 33 |
|
|
2015
Q3 | $3.17M | Buy |
58,263
+11,220
| +24% | +$730K | 0.54% | 17 |
|
|
2015
Q2 | $3.16M | Sell |
47,043
-1,579
| -3% | -$103K | 0.5% | 14 |
|
|
2015
Q1 | $2.85M | Sell |
48,622
-340
| -0.7% | -$20.5K | 0.45% | 16 |
|
|
2014
Q4 | $3.2M | Sell |
48,962
-3,933
| -7% | -$248K | 0.48% | 14 |
|
|
2014
Q3 | $3.06M | Sell |
52,895
-4,820
| -8% | -$268K | 0.46% | 15 |
|
|
2014
Q2 | $3.26M | Buy |
57,715
+310
| +0.5% | +$16.3K | 0.44% | 16 |
|
|
2014
Q1 | $2.95M | Sell |
57,405
-2,166
| -4% | -$109K | 0.41% | 17 |
|
|
2013
Q4 | $3.15M | Buy |
59,571
+11,006
| +23% | +$541K | 0.41% | 21 |
|
|
2013
Q3 | $2.17M | Sell |
48,565
-6,490
| -12% | -$288K | 0.33% | 28 |
|
|
2013
Q2 | $2.28M | Buy |
+55,055
| New | +$2.41M | 0.36% | 20 |
|
Other funds holding ABBV
HighTower Trust's ABBV Position: Q1 2023 in Review
HighTower Trust increased its AbbVie (ABBV) stake by 0.55% in Q1 2023, buying an estimated $15.1K and bringing the position to 18,040 shares worth $2.7M. The position accounts for 0.26% of the portfolio, ranked #64.
HighTower Trust first reported a position in ABBV in Q2 2013 and has held it in 40 quarters since. The position peaked at $4.02M in Q1 2022. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.
- HighTower Trust held 18,040 shares of AbbVie worth $2.7M as of Q1 2023.
- HighTower Trust bought 99 AbbVie shares in Q1 2023, an estimated $15.1K.
- AbbVie made up 0.26% of HighTower Trust's portfolio in Q1 2023, its #64 holding.
- HighTower Trust first reported a position in AbbVie in Q2 2013 and has held it in 40 quarters since.
- HighTower Trust's AbbVie position peaked at $4.02M in Q1 2022.
- 3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.
Based on HighTower Trust's 13F filing for Q1 2023, filed 21 Apr 2023.